ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Clinical trial NCT06693830 · RECRUITING

Trial details

NCT number: NCT06693830
Sponsor: Hua-Jay J Cherng, MD
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lymphoma Lymphoma, B-Cell Diffuse Large B Cell Lymphoma Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High-grade B-cell Lymphoma

Start date: 2024-12-11
Primary completion: 2027-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.